24-Hour Blood Pressure Monitoring with Ring... Daewoong Pharmaceutical Signs Licensing Agreement for 'CartOneBP'

World's First Ring-Type Blood Pressure Monitor
Healthcare Startup Skylabs Signs Domestic Distribution Agreement

SkyLabs' ring-type continuous blood pressure monitor 'CartOneBP'.
[Photo by Daewoong Pharmaceutical]

Daewoong Pharmaceutical introduces a ring-shaped 24-hour continuous blood pressure monitor.

On the 7th, Daewoong Pharmaceutical announced on the 8th that it held a domestic distribution rights contract signing ceremony for the ring-shaped continuous blood pressure monitor 'CartOneBP' with digital healthcare startup Skylabs at Daewoong Pharmaceutical headquarters in Samseong-dong, Gangnam-gu, Seoul.

Through this contract, Daewoong Pharmaceutical will hold exclusive domestic sales rights and will begin full-scale distribution to hospitals and clinics nationwide starting in September. Daewoong Pharmaceutical plans to expand into the diagnosis and management of cardiovascular diseases such as hypertension and heart failure through this.

Skylabs' continuous blood pressure monitor CartOneBP is the world's first ring-shaped blood pressure monitor adopting a 'cuffless' method rather than the traditional 'cuff' method that compresses the upper arm to measure blood pressure. It received approval from the Ministry of Food and Drug Safety in March. CartOneBP measures blood pressure using photoplethysmography, a light-based pulse measurement method. It can be worn on the finger for 24-hour continuous monitoring and features waterproof capabilities, allowing use during exercise, showering, and rainy weather.

The company explained that CartOneBP improves on the drawbacks of existing cuff-type 24-hour blood pressure monitors, such as discomfort causing sleep disturbances and pain from repeated compression. Users can conveniently check blood pressure changes by time period via a smartphone app and receive various blood pressure data. Additionally, based on the collected data, medication dosages can be adjusted, and real-time monitoring of responses after alcohol consumption or blood pressure medication intake is possible.

CartOneBP will first be released for hospital use and is scheduled to be launched for general consumers through online markets around the end of this year.

Lee Chang-jae, CEO of Daewoong Pharmaceutical, said, "The synergy effect can be achieved when the world’s most innovative continuous blood pressure monitor CartOneBP’s technology and Daewoong Pharmaceutical’s sales and marketing capabilities come together. Daewoong Pharmaceutical and Skylabs will provide optimized diagnostic technology and treatment solutions to improve the quality of life for the 12 million hypertension patients in Korea."

Lee Byung-hwan, CEO of Skylabs, stated, "Our goal is to fundamentally improve the lives of patients outside hospitals by expanding management not only to effective and easy hypertension treatment and management in daily life but also to nocturnal hypertension during sleep, whose importance has recently greatly increased."

Lee Chang-jae, CEO of Daewoong Pharmaceutical (right), and Lee Byung-hwan, CEO of Skylabs, are posing for a commemorative photo after signing the domestic distribution rights contract for the ring-type blood pressure monitor CartOneBP.
[Photo by Daewoong Pharmaceutical]

This content was produced with the assistance of AI translation services.